Allergy medication recalled after drug mix-up that could be life-threatening: FDA
Unique Pharmaceutical Laboratories has issued a voluntary recall for four lots of Cetirizine Hydrochloride Tablets USP 5 mg. The recall affects the 5 mg strength of this common allergy medication.
The company initiated this action after discovering cross-contamination with Ranitidine. Ranitidine is a medication typically used to manage heartburn and severe acid reflux.
Regulators at the Food and Drug Administration warn that this mix-up creates significant health risks. The contamination is dangerous for individuals with specific hypersensitivities to the ingredients found in the heartburn medication.
The recall process began on July 18 and aims to remove the affected products from the consumer level. Consumers should check their medicine cabinets for the specific lots mentioned in the official recall notice and stop use immediately if they possess these items. Medical professionals suggest contacting a pharmacist to confirm if a specific batch of medication is part of this recall.
No further details regarding the extent of the distribution or reports of adverse reactions were provided at this time. This remains an active situation with the government agency monitoring the manufacturer to ensure the product is removed from circulation.